These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24535229)

  • 1. A COX-2 inhibitor enhances the antitumor effects of chemotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Yusup G; Akutsu Y; Mutallip M; Qin W; Hu X; Komatsu-Akimoto A; Hoshino I; Hanari N; Mori M; Akanuma N; Isozaki Y; Matsubara H
    Int J Oncol; 2014 Apr; 44(4):1146-52. PubMed ID: 24535229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in esophageal carcinoma cell lines.
    Ando T; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Sugito N; Mori R; Ogawa R; Katada T; Fujii Y
    Dis Esophagus; 2008; 21(1):15-20. PubMed ID: 18197934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase.
    Réti A; Pap E; Adleff V; Jeney A; Kralovánszky J; Budai B
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):219-27. PubMed ID: 19830428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose hyperthermia enhances the antitumor effects of chemotherapy in squamous cell carcinoma.
    Hu X; Akutsu Y; Suganami A; Qin W; Hanari N; Murakam K; Kano M; Usui A; Suito H; Takahashi M; Matsumoto Y; Otsuta R; Tamura Y; Matsubara H
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 30052898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y; Harada K; Ferdous T; Yoshida H
    Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of cyclooxygenase-2 inhibition with celecoxib combined with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a subcutaneous implantation tumor model of human colon cancer.
    Zhang DQ; Guo Q; Zhu JH; Chen WC
    World J Surg Oncol; 2013 Jan; 11():16. PubMed ID: 23347845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib antagonizes the cytotoxicity of cisplatin in human esophageal squamous cell carcinoma cells by reducing intracellular cisplatin accumulation.
    Yu L; Chen M; Li Z; Wen J; Fu J; Guo D; Jiang Y; Wu S; Cho CH; Liu S
    Mol Pharmacol; 2011 Mar; 79(3):608-17. PubMed ID: 21177414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of 5-fluorouracil-related enzymes in pulmonary neuroendocrine carcinoma: differences in biological properties compared to epithelial carcinoma.
    Nagasaki T; Tsuchiya T; Tagawa T; Honda S; Yamasaki N; Miyazaki T; Hidaka S; Hayashi T; Nagayasu T
    Clin Lung Cancer; 2010 Nov; 11(6):412-22. PubMed ID: 21062732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
    Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
    Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of inhibitors of nitric oxide synthase or cyclooxygenase-2 on human KB carcinoma cells overexpressing COX-2.
    Ohtsu N; Takaoka K; Segawa E; Hashitani S; Noguchi K; Kishimoto H; Urade M
    Oncol Rep; 2010 Jul; 24(1):31-6. PubMed ID: 20514441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of non-steroidal anti-inflammatory drugs to enhance 5-fluorouracil efficacy in experimental systems].
    Réti A
    Magy Onkol; 2010 Dec; 54(4):377-81. PubMed ID: 21163769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orotate phosphoribosyl transferase mRNA expression in oral squamous cell carcinoma and its relationship with the dihydropyrimidine dehydrogenase expression and the clinical effect of 5-fluorouracil.
    Yoshitomi I; Kawasaki G; Yanamoto S; Mizuno A
    Oral Oncol; 2006 Oct; 42(9):880-7. PubMed ID: 16757204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines.
    Miyazaki K; Shibahara T; Sato D; Uchida K; Suzuki H; Matsui H; Yanaka A; Nakahara A; Matsuzaki Y
    J Gastroenterol; 2006 Feb; 41(2):140-50. PubMed ID: 16568373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between 5-fluorouracil (5-FU) sensitivity as measured by collagen gel droplet embedded culture drug sensitivity test (CD-DST) and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
    Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Kihara A; Okano M
    Gan To Kagaku Ryoho; 2001 May; 28(5):661-7. PubMed ID: 11383215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma.
    Kwak YE; Jeon NK; Kim J; Lee EJ
    Ann N Y Acad Sci; 2007 Jan; 1095():99-112. PubMed ID: 17404023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Four resected cases with basaloid carcinoma of esophagus--comparison of 5-FU-related enzymes (thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), orotate phosphoribosyl transferase (OPRT)) between basaloid carcinoma and squamous cell carcinoma].
    Takemura M; Morimura K; Yoshida K; Fujiwara Y
    Gan To Kagaku Ryoho; 2010 Nov; 37(11):2143-6. PubMed ID: 21084814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of celecoxib on PGE2 synthesis and COX-2 and VEGF-C mRNA expression in Tca8113 cell lines].
    Li WZ; Wang XY; Ding YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):466-8. PubMed ID: 19304526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.